Authors: GIGLER G SZABADOS T SIMO A GYERTYAN I LEVAY G

Citation: G. Gigler et al., THE EFFECTS OF AMPA ANTAGONIST GYKI-52466 AND 2 ANALOGS (GYKI-53405, GYKI-53655) IN ANTIISCHEMIC ANTIEPILEPTIC MODELS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35111-35111

Authors: SZENDROVITS AZ SZABADOS T

Citation: Az. Szendrovits et T. Szabados, ON THE LEAST-COST SAFETY INVENTORY FOR LARGE TRANSFER LINES, Omega, 25(4), 1997, pp. 483-487

Authors: SZABADOS T GIGLER G GACSALYI I LEVAY G

Citation: T. Szabados et al., FURTHER EVIDENCES OF ANTIEPILEPTIC AND ANTIISCHEMIC ACTIVITY OF GYKI-53405 AND GYKI-53655, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 57-57

Authors: SEBOK B SZABADOS T KERENYI M SCHNEIDER I MAHRLE G

Citation: B. Sebok et al., EFFECT OF FUMARIC-ACID, ITS DIMETHYLESTER, AND TOPICAL ANTIPSORIATIC DRUGS ON EPIDERMAL DIFFERENTIATION IN THE MOUSE TAIL MODEL, Skin pharmacology, 9(2), 1996, pp. 99-103

Authors: SZENDROVITS AZ SZABADOS T

Citation: Az. Szendrovits et T. Szabados, LEAST-COST SAFETY INVENTORY FOR LARGE TRANSFER LINES, Omega, 21(4), 1993, pp. 471-480